Study Title | INTER-EWING-1: INTERnational scientific program in clinical research to improve outcomes of newly diagnosed EWING sarcoma |
---|---|
Protocol ID | RG_21-151 (INTER-EWING-1) |
Disease (Sub Disease) | Ewing Sarcoma |
Diagnosis Stage | Newly Diagnosed |
Location | VIC / WA / NZ |
Sponsor | Australian and New Zealand Children's Haematology Oncology Group/ University of Birmingham |
Links | https://www.isrctn.com/ISRCTN17938906 |
Trial Status | Open |
Trial Open Date | 21/06/2024 |
Sites | Perth Children's Hospital/ Peter MacCallum Cancer Centre/ Starship Children's Hospital / Christchurch Hospital / |
Study Type | Treatment |
Phase | Phase 3 |
Age Eligibility | ≥2 years |
ANZCTR | ACTRN12624000532505 |
International registry ID's | ISRCTN17938906 |